Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer

Science

Volumn 356, Issue 6334, 2017, Pages 200-205

  Stevanović, Sanja ^a   Pasetto, Anna ^a   Helman, Sarah R ^a   Gartner, Jared J ^a   Prickett, Todd D ^a   Howie, Bryan ^b   Robins, Harlan S ^b,c   Robbins, Paul F ^a   Klebanoff, Christopher A ^d,e   Rosenberg, Steven A ^a   Hinrichs, Christian S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ADAPTIVE BIOTECHNOLOGIES   (United States)

^c USA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Ludwig Center for Cancer Immunotherapy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KITA KYUSHU LUNG CANCER ANTIGEN 1; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; E7 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR; REPRESSOR PROTEIN;

ANTIGEN; CANCER; CELLS AND CELL COMPONENTS; DISEASE TREATMENT; GENE EXPRESSION; IMMUNIZATION; TUMOR;

ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL POPULATION; EPITHELIUM TUMOR; HUMAN; IMMUNOGENETICS; IN VIVO STUDY; LYMPHOCYTE FUNCTION; METASTATIC CERVICAL CANCER; PRIORITY JOURNAL; SOMATIC MUTATION; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNOGENICITY; TUMOR REGRESSION; UTERINE CERVIX CANCER; VIRUS INDUCED EPITHELIAL CANCER; WART VIRUS; ADOPTIVE IMMUNOTHERAPY; ANTAGONISTS AND INHIBITORS; COMPLICATION; FEMALE; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOLOGY; METABOLISM; PAPILLOMAVIRUS INFECTION; PROCEDURES; SQUAMOUS CELL CARCINOMA; TRANSPLANTATION; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTES, TUMOR-INFILTRATING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PROGRAMMED CELL DEATH 1 RECEPTOR; REPRESSOR PROTEINS; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS;

EID: 85018517925     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aak9510     Document Type: Article

References (29)

1. S. Stevanović et al., J. Clin. Oncol. 33, 1543-1550 (2015).
2. T. Y. Seiwert et al., Lancet Oncol. 17, 956-965 (2016).
3. V. K. Morris, K. K. Ciombor, M. E. Salem, J. Clin. Oncol. 34 (suppl.), abstr. 3503 (2016).
4. S. H. van der Burg, C. J. Melief, Curr. Opin. Immunol. 23, 252-257 (2011).
5. G. G. Kenter et al., Clin. Cancer Res. 14, 169-177 (2008).
6. M. I. van Poelgeest et al., J. Transl. Med. 11, 88 (2013).
7. M. J. Welters et al., Sci. Transl. Med. 8, 334ra52 (2016).
8. N. A. Rizvi et al., Science 348, 124-128 (2015).
9. E. Tran et al., Science 344, 641-645 (2014).
10. E. M. Van Allen et al., Science 350, 207-211 (2015).
11. N. van Rooij et al., J. Clin. Oncol. 31, e439-e442 (2013).
12. P. Kvistborg et al., OncoImmunology 1, 409-418 (2012).
13. P. F. Robbins et al., Clin. Cancer Res. 21, 1019-1027 (2015).
14. Y. C. Lu et al., Clin. Cancer Res. 20, 3401-3410 (2014).
15. A. Pasetto et al., Cancer Immunol. Res. 4, 734-743 (2016).
16. B. Howie et al., Sci. Transl. Med. 7, 301ra131 (2015).
17. A. Gros et al., Nat. Med. 22, 433-438 (2016).
18. S. Duensing, K. Münger, Int. J. Cancer 109, 157-162 (2004).
19. C. A. Moody, L. A. Laimins, Nat. Rev. Cancer 10, 550-560 (2010).
20. L. B. Alexandrov et al., Nature 500, 415-421 (2013).
21. A. I. Ojesina et al., Nature 506, 371-375 (2014).
22. Catalogue of somatic mutations in cancer (COSMIC) database;http://cancer.sanger.ac.uk/cosmic.
23. E. Strønen et al., Science 352, 1337-1341 (2016).
24. A. Shida et al., Anticancer Res. 35, 3575-3579 (2015).
25. C. Paret et al., Oncotarget 6, 25356-25367 (2015).
26. T. Fukuyama et al., Cancer Res. 66, 4922-4928 (2006).
27. P. J. de Vos van Steenwijk et al., Cancer Res. 70, 2707-2717 (2010).
28. S. J. Piersma et al., Int. J. Cancer 122, 486-494 (2008).
29. L. M. Draper et al., Clin. Cancer Res. 21, 4431-4439 (2015).